1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Cancer Photodynamic Therapy Market & Cancer  Photosensitisers  Clinical Trial Outlook 2023

Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2023

  • September 2017
  • 170 pages
  • ID: 5094280
  • Format: PDF
  • By Kuick Research

Summary

Table of Contents

Efficacy and safety of a therapeutic method has always been the prime concern during treatment of an ailment. Any therapeutic method that fulfills the above criteria has been deemed to be a successful procedure. Nonetheless, patients and health professionals not only seek the efficacy and safety of a treatment method, but also look into it being a non- invasive procedure involving minimal to no pain. It is evident that such a procedure would be a blockbuster therapeutic .This is what the Photodynamic Therapy (PDT) currently aims to do.

Initially, the therapeutic property of Photodynamic Therapy was explored and limited to killing of microbes such as bacteria, fungi and viruses. It slowly evolved and was soon observed to be effective in the treatment of skin conditions such as acne and psoriasis further advancing to show effective results in complex conditions like atherosclerosis and herpes. Its impressive results in the above mentioned disease led scientists to explore its ability in the treatment of cancer which eventually led to a whole new segment of photodynamic therapy dedicated to the effective, noninvasive, safe and easier method of cancer treatment using light.

The photodynamic therapy market is currently segmented into four divisions of acne, cancer, atherosclerosis and psoriasis with acne and cancer currently leading with majority of research and development being focused in these aspects of the photodynamic therapy due to their steep demand. Recently, the Photodynamic therapy for various types of cancer like breast cancer, head and neck cancer and lung cancer has been receiving increased attention due to its innovative and noninvasive feature which is currently in high demand globally , that has further led to a steady growth in the photodynamic therapy market.

“Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2023” Report Highlight:

• Working Mechanism of the Photodynamic Cancer Therapy
• Photosensitizer Delivery
• Anti-Tumor Activity of the Photodynamic Therapy
• Status of Various Cancer Treatments Using Photodynamic Therapy
• Promising Advances in the Photodynamic Therapy Segment
• Photodynamic Combinational Cancer Therapy
• Global Cancer Photosensitisers Clinical Pipeline by Company & Phase
• Marketed Cancer Photosensitisers Clinical Insight

An insight into the global presence of photodynamic therapy shows that currently photodynamic therapy is widely being used in the developed countries like the UK, US and Russia. Unlike few years ago, when photodynamic therapy had just entered the market, it is currently found to be much more prevalent suggesting the steady growth of the photodynamic therapy market .several major hospitals in the US offer cancer treatment alternative using photodynamic therapy especially for the skin cancer related disease and lesion. This trend is bound to rise steadily with the increasing awareness among both the general public and the healthcare professionals

Currently, photodynamic therapy has shown promising results in the pre-clinical studied of prostate cancer, breast cancer, lung cancer, head and neck cancer and colorectal cancer. A few forms of cancers like the oesophageal cancer and colorectal cancer have been treated using photodynamic therapy in the developing countries, however majority of them are still under vigorous study in the clinical pipeline which is anticipated to be approved in a few years. Until then Photodynamic therapy has largely been approved and used in the palliative treatment of almost all types of cancer for the removal of residual tumor cells, thus prolonging the remission period of cancer.

The progress in the photodynamic therapy segment also suggests that someday it could help in the treatment of larger and deep tumors, which is currently not possible due to the low penetration of light. A technique known as interstitial therapy involving the use of imaging tests like computed tomography (CT) scans to guide fiber optics directly into tumors using needles is slowly developing. Early results in clinical and pre-clinical phase have shown that it could immensely helpful in the successful treatment of head and neck, prostate and liver tumors. Thus a thorough insight into the photodynamic therapy progress and its current scenario leads to the conclusion that photodynamic therapy deserves more attention and a central position in the treatment of cancer. It should be promoted and encouraged as part of a multimodal approach or a standalone treatment for early disease, palliative care or as a salvage treatment.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 - Pipeline Review, H2 2019

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 - Pipeline Review, H2 2019SummaryInduced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 ...

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019’; Interleukin ...

Bcl 2 Like Protein 1 - Pipeline Review, H2 2019

Bcl 2 Like Protein 1 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Bcl 2 Like Protein 1 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Pipeline Review, H2 2019’; Bcl ...


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on